IE
VCNX

Israel Englander’s Vaccinex, Inc. Common Stock VCNX Stock Holding History

Israel Englander’s Portfolio VCNX Stock Details VCNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-983
Closed -$15.5K – 6658
2023
Q3 		$15.5K Buy
+983
New +$49.9K ﹤0.01% 5695
2023
Q2 		– Sell
-529
Closed -$44K – 6837
2023
Q1 		$44K Buy
529
+348
+192% +$38.2K ﹤0.01% 5663
2022
Q4 		$25K Sell
181
-156
-46% -$19.3K ﹤0.01% 5989
2022
Q3 		$35K Sell
337
-385
-53% -$75.6K ﹤0.01% 6298
2022
Q2 		$164K Buy
722
+575
+391% +$147K ﹤0.01% 5726
2022
Q1 		$41K Buy
+147
New +$40.6K ﹤0.01% 6454
2020
Q3 		– Sell
-147
Closed -$111K – 4903
2020
Q2 		$111K Sell
147
-65
-31% -$50.7K ﹤0.01% 3964
2020
Q1 		$178K Sell
212
-57
-21% -$64.6K ﹤0.01% 3429
2019
Q4 		$274K Sell
269
-43
-14% -$48.5K ﹤0.01% 3707
2019
Q3 		$469K Sell
312
-7
-2% -$7.88K ﹤0.01% 3306
2019
Q2 		$369K Sell
319
-17
-5% -$22.7K ﹤0.01% 3429
2019
Q1 		$371K Sell
336
-13
-4% -$12.5K ﹤0.01% 3430
2018
Q4 		$276K Sell
349
-50
-13% -$61.1K ﹤0.01% 3256
2018
Q3 		$580K Buy
+399
New +$824K ﹤0.01% 3161

Other funds holding VCNX

ACM
AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return
WVP
Worth Venture Partners Fort Lee, New Jersey $44.3M AUM 34.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $7.72B AUM 32.88% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $71.1B AUM 128.96% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Israel Englander's VCNX Position: Q4 2023 in Review

Israel Englander sold out of Vaccinex, Inc. Common Stock (VCNX) in Q4 2023, closing a stake of 983 shares — an estimated $15.5K sold.

Israel Englander first reported a position in VCNX in Q3 2018 and held it in 14 quarters. The position peaked at $580K in Q3 2018. 17 funds tracked by Wall St. Rank hold VCNX as of Q4 2023.

  • Israel Englander reported no remaining Vaccinex, Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
  • Israel Englander sold 983 Vaccinex, Inc. Common Stock shares in Q4 2023, an estimated $15.5K.
  • Israel Englander first reported a position in Vaccinex, Inc. Common Stock in Q3 2018 and held it in 14 quarters.
  • Israel Englander's Vaccinex, Inc. Common Stock position peaked at $580K in Q3 2018.
  • 17 funds tracked by Wall St. Rank held Vaccinex, Inc. Common Stock as of Q4 2023.

Based on Millennium Management's 13F filing for Q4 2023, filed 14 Feb 2024.